Same Day Mid-Throughput Sequencing
Sponsored content brought to you by
In genome sequencing, everything needs to be just right. It should be just right in terms of data quality, turnaround time, cost, and equipment ease of use. In some...
BIOHIT introduces the FAEX™ Sample System for stool sample collection and handling
BIOHIT OYJ is excited to announce the launch of the BIOHIT FAEX Sample System, a revolutionary stool sample collection and handling solution that can be seamlessly incorporated into any diagnostic workflow. Designed for precision,...
AI Model Analyzes ECGs to Spotlight Female Patients at Elevated Risk for Heart Disease
A groundbreaking study published in The Lancet Digital Health has revealed a significant advancement in the detection of heart disease risk in women through the use of artificial intelligence (AI). This innovative AI model...
Healx Candidate, SpringWorks Therapy Expand NF1 Treatment Options
The start of human dosing in a clinical trial Monday, plus a drug approval earlier this month, together offer the potential to reshape the treatment of the rare disease neurofibromatosis type 1 (NF1).
Healx, an...
Insilico Medicine reaches preclinical milestone in MASH drug discovery
Insilico Medicine("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, recently achieved preclinical milestone in its collaboration with Therasid Bioscience, a South Korean based biotechnology company focuses on developing innovative first-in-class drugs for...
Study Finds Antidepressants May Accelerate Cognitive Decline in Dementia Patients
New research reveals concerning insights into the impact of antidepressants on cognitive decline among dementia patients, suggesting that these widely prescribed medications might exacerbate the very symptoms they aim to alleviate. Published in the...
New drug ataciguat shows promise for managing aortic valve stenosis
Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally. Researchers at Mayo Clinic are exploring the use of a new drug called ataciguat to manage AVS. Results from...
Decoding Drug Mechanism of Action with Chromatin Mapping Assays
REGISTER NOWBroadcast Date: Wednesday, March 26, 2025Time: 8:00 am PT, 11:00 am ET, 16:00 CETUnderstanding a drug’s mechanism of action (MOA) can greatly increase the likelihood of successful clinical trials by identifying biomarkers of...
StockWatch: Bluebird Bio Plunges on Buyout, as Gene Therapy’s Woes Grow
Bluebird Bio (NASDAQ: BLUE) said its planned acquisition by two investment firms is, according to its board, “in the best interest of stockholders”—but enough of them felt otherwise on Friday to have sent the...
Review calls for better poverty metrics in tuberculosis research
Tuberculosis (TB) has long been recognized as a disease of poverty, yet most TB research does not measure poverty in a meaningful way. A new review in the journal BMC Global and Public Health...
